Dmitry Balyasny’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDL
MI
Dmitry Balyasny's CRDL Position: Q3 2026 in Review
Dmitry Balyasny opened a new position in Cardiol Therapeutics (CRDL) in Q3 2026: 207,277 shares worth $344K. The stake represents ﹤0.01% of the portfolio and ranks #2703 among its holdings.
59 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.
- Dmitry Balyasny held 207,277 shares of Cardiol Therapeutics worth $344K as of Q3 2026.
- Cardiol Therapeutics was a new Dmitry Balyasny position in Q3 2026.
- Cardiol Therapeutics made up ﹤0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #2703 holding.
- 59 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.